The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
First-Trimester Screening for Trisomies 21 and 18
Open accessAbstract
BACKGROUND: Screening for aneuploid pregnancies is routinely performed after 15 weeks of gestation and has a sensitivity of approximately 65 percent, with a false positive rate of 5 percent. First-trimester markers of aneuploidy have been developed, but their use in combination has not been adequately evaluated in clinical practice. METHODS: We conducted a multicenter study of screening for trisomies 21 and 18 among patients with pregnancies between 74 and 97 days of gestation, based on maternal age, maternal levels of free beta human chorionic gonadotropin and pregnancy-associated plasma protein A, and ultrasonographic measurement of fetal nuchal translucency. A screening result was considered to be positive for trisomy 21 if the calculated risk was at least 1 in 270 pregnancies and positive for trisomy 18 if the risk was at least 1 in 150. RESULTS: Screening was completed in 8514 patients with singleton pregnancies. This approach to screening identified 85.2 percent of the 61 cases of Down's syndrome (95 percent confidence interval, 73.8 to 93.0), with a false positive rate of 9.4 percent (95 percent confidence interval, 8.8 to 10.1). At a false positive rate of 5 percent, the detection rate was 78.7 percent (95 percent confidence interval, 66.3 to 88.1). Screening identified 90.9 percent of the 11 cases of trisomy 18 (95 percent confidence interval, 58.7 to 99.8), with a 2 percent false positive rate. Among women 35 years of age or older, screening identified 89.8 percent of fetuses with trisomy 21, with a false positive rate of 15.2 percent, and 100 percent of fetuses with trisomy 18. CONCLUSIONS: First-trimester screening for trisomies 21 and 18 on the basis of maternal age, maternal levels of free beta human chorionic gonadotropin and pregnancy-associated plasma protein A, and measurement of fetal nuchal translucency has good sensitivity at an acceptable false positive rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snijders, R., Noble, P., Sebire, N., Souka, A., & Nicolaides, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11280-6 · Cited by 1,572
Wald, N. J., Watt, H. C., & Hackshaw, A. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410701 · Cited by 530
Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study
Cicero, S., Curcio, P., Papageorghiou, A., Sonek, J., & Nicolaides, K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06709-5 · Cited by 527
Maternal age‐ and gestation‐specific risk for trisomy 21
Snijders, R. J. M., Sundberg, K., Holzgreve, W., Henry, G., & Nicolaides, K. H. (1999) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.1999.13030167.x · Cited by 367
Self-citationPCR Quantitation of Fetal Cells in Maternal Blood in Normal and Aneuploid Pregnancies
Bianchi, D. W., Williams, J. M., Sullivan, L. M., Hanson, F. W., Klinger, K. W., & Shuber, A. P. (1997) · The American Journal of Human Genetics · doi:10.1086/514885 · Cited by 366
Increased Fetal DNA Concentrations in the Plasma of Pregnant Women Carrying Fetuses with Trisomy 21
Lo, Y. D., Lau, T. K., Zhang, J., Leung, T. N., Chang, A. M., Hjelm, N. M., Elmes, R. S., & Bianchi, D. W. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.10.1747 · Cited by 298
Screening of Maternal Serum for Fetal Down's Syndrome in the First Trimester
Haddow, J. E., Palomaki, G. E., Knight, G. J., Williams, J., Miller, W. A., & Johnson, A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381404 · Cited by 232
Self-citationFetal loss in Down syndrome pregnancies
Morris, J. K., Wald, N. J., & Watt, H. (1999) · Prenatal Diagnosis · Cited by 221
Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses
Yan Zhong, X., B�rk, M. R., Troeger, C., Jackson, L. R., Holzgreve, W., & Hahn, S. (2000) · Prenatal Diagnosis · doi:10.1002/1097-0223(200010)20:10<795::aid-pd897>3.0.co;2-p · Cited by 181
Self-citationFirst-Trimester down syndrome screening using dried blood biochemistry and nuchal translucency
Krantz, D. (2000) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)00881-4 · Cited by 168
Self-citationSnijders, R. J. M., Thom, E. A., Zachary, J. M., Platt, L. D., Greene, N., Jackson, L. G., Sabbagha, R. E., Filkins, K. A., Silver, R. K., Hogge, W. A., et al. (2002) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.2002.00637.x · Cited by 145
Self-citationZhang, D. D., Zhou, X., Freeman, D. H., & Freeman, J. L. (2002) · Statistics in Medicine · doi:10.1002/sim.1011 · Cited by 137
Antenatal screening for Down's syndrome with the quadruple test
Wald, N., Huttly, W. J., & Hackshaw, A. K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12680-3 · Cited by 132
Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy
BORRELL, A., Antolin, E., Costa, D., et al. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70034-1 · Cited by 105
Established markers in second trimester maternal serum
Cuckle, H. (1996) · Early Human Development · doi:10.1016/s0378-3782(96)01814-2 · Cited by 55
Schuchter, K., Hafner, E., Stangl, G., Ogris, E., & Philipp, K. (2001) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.2001.00458.x · Cited by 44
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood
Fan, H. C., Blumenfeld, Y. J., Chitkara, U., Hudgins, L., & Quake, S. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808319105 · Cited by 1,114
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407349 · Cited by 817
Self-citationScreening for fetal aneuploidies at 11 to 13 weeks
Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2637 · Cited by 642
Metadata
- Authors
- Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., Wilson, R. D., Mohide, P., Hershey, D., Krantz, D., Zachary, J., Snijders, R., Greene, N., Sabbagha, R., MacGregor, S., Hill, L., Gagnon, A., Hallahan, T., & Jackson, L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-09
- Volume
- 349
- Issue
- 15
- Pages
- 1405-1413
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2136826099
- Cited by
- 563
- References
- 16
- FWCI
- 40.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.